Search

everythinglearnresearchcommunity

for

Search:↓

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

FCO2 laser is a better treatment for alopecia areata than intralesional steroids.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

People with alopecia areata may be more likely to have a certain type of hearing loss.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Hair loss can cause serious mental health problems and treating it requires a team of experts.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

A young girl had both alopecia areata and immune thrombocytopenic purpura at the same time, suggesting a possible link between the two.

High-frequency ultrasonography can be a useful tool for diagnosing different stages of alopecia areata, a type of hair loss.

Too much epidermal growth factor can cause hair loss.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Eosinophilic esophagitis may trigger alopecia areata in some patients.